Pemecine - Pemetrexed
Product Description
PTCKD OTTO Pharmaceuticals
-
ID -
2022On CPHI since
-
3Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Specifications
PTCKD OTTO Pharmaceuticals
-
ID
-
2022On CPHI since
-
3Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from PTCKD OTTO Pharmaceuticals (2)
-
Product Tezobell - Bortezomib
Composition: Bortezomib 3.5 mg
Indication:
The treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy.
Packed in : Dry vial 3.5 mg -
Product Belloxa - Oxaliplatin
Composition Oxaliplatin 50 mg &100 mg
Indication
Adjuvant treatment of stage III colon cancer (Duke stage C) after complete resection of initial tumor, treatment of metastatic colorectal cancer
Recommended Products
-
Product products
Tablets 1ZefinibGefitinib250mg1 x 10 2CapetazCapecetabine500mg1 x 10 3AnastrozAnastrozole1mg1 x 10 4ZutamTamoxifen20mg1 x 10 5ZuvitrexMethotrexate 2.5mg1 x 10 6ZuvitrexMethotrexate7.5mg1 x 10 7ErlononErlotinib100mg1 x 10 8ErlononErlotinib150mg1 x 10 9ZuvitrozLetrozole...
-
Product CDMO
• Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY • CYTOTOXIC API • EU GMP • JGMP (Japan) • KGMP (Korea) • PIC/S
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance